Security Snapshot

ISHARES TR - RUS 1000 VAL ETF (IWD) Institutional Ownership

CUSIP: 464287598

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

1,886

Shares (Excl. Options)

267,768,991

Price

$213.67

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0.11%
Share change
-5,180,733
Value change
-$1,103,267,450
Number of holders
1,886
Issuer context Names, identifiers, and filing context for this profile. 1 identity field
SEC-reported price per share
$233.90
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • IWD - ISHARES TR - RUS 1000 VAL ETF is tracked under CUSIP 464287598.
  • 1886 institutions reported positions in Q1 2026.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 1,898 to 1,886 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $57,465,222,715 to $57,188,459,736.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 1886 institutions filings for Q1 2026.

Open SEC evidence

Security key

464287598

Latest holder period

Q1 2026

13F holders

1,886

13D/G owners

0

CIK / CUSIP context first

As of 31 Mar 2026, 1,886 institutional investors reported holding 267,768,991 shares of ISHARES TR - RUS 1000 VAL ETF (IWD).

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
49
Latest
Q1 2026
Rows shown
1-25 of 49
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 267,768,991 $57,188,459,736 -$1,103,267,450 $213.67 1,886
2025 Q4 273,115,827 $57,465,222,715 +$3,194,771,674 $210.34 1,898
2025 Q3 254,767,180 $51,865,703,814 -$430,584,973 $203.59 1,739
2025 Q2 257,742,844 $50,052,390,802 -$1,931,855,720 $194.23 1,717
2025 Q1 267,836,091 $50,368,074,314 -$1,744,247,125 $188.16 1,697
2024 Q4 278,730,975 $51,607,612,223 +$4,185,405,566 $185.13 1,721
2024 Q3 253,375,705 $48,085,143,938 -$469,091,941 $189.80 1,569
2024 Q2 255,582,836 $44,615,479,275 +$829,170,746 $174.47 1,509
2024 Q1 252,013,893 $45,132,818,026 -$2,872,190,005 $179.11 1,528
2023 Q4 268,933,714 $44,437,223,449 +$2,517,420,383 $165.25 1,547
2023 Q3 250,755,933 $38,071,771,784 -$378,746,418 $151.82 1,436
2023 Q2 253,159,901 $39,955,844,110 -$1,208,121,110 $157.83 1,412
2023 Q1 258,990,963 $39,427,540,378 -$3,664,738,204 $152.26 1,401
2022 Q4 285,602,660 $43,316,233,002 +$1,168,004,365 $151.65 1,454
2022 Q3 277,351,519 $37,737,705,778 -$188,455,970 $135.99 1,307
2022 Q2 278,868,069 $40,476,688,935 +$411,862,609 $144.97 1,337
2022 Q1 276,789,847 $45,958,016,748 -$1,327,856,376 $165.98 1,369
2021 Q4 285,023,814 $47,842,898,101 +$2,953,749,992 $167.93 1,382
2021 Q3 266,137,579 $41,709,181,575 +$724,318,927 $156.51 1,220
2021 Q2 261,647,672 $41,513,650,599 +$141,416,133 $158.62 1,221
2021 Q1 261,565,533 $39,651,910,147 +$1,376,686,411 $151.55 1,189
2020 Q4 251,578,469 $34,402,657,212 +$1,438,558,198 $136.73 1,145
2020 Q3 241,199,787 $28,461,617,398 +$266,311,879 $118.13 996
2020 Q2 238,884,336 $26,868,348,971 -$1,263,336,650 $112.62 979
2020 Q1 250,584,701 $24,845,411,769 +$2,418,740,980 $99.18 984
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .